title: The World Hypertension League: where now and where to in salt reduction.
abstract: High dietary salt is a leading risk for death and disability largely by causing increased blood pressure. Other associated health risks include gastric and renal cell cancers, osteoporosis, renal stones, and increased disease activity in multiple sclerosis, headache, increased body fat and Meniere's disease. The World Hypertension League (WHL) has prioritized advocacy for salt reduction. WHL resources and actions include a non-governmental organization policy statement, dietary salt fact sheet, development of standardized nomenclature, call for quality research, collaboration in a weekly salt science update, development of a process to set recommended dietary salt research standards and regular literature reviews, development of adoptable power point slide sets to support WHL positions and resources, and critic of weak research studies on dietary salt. The WHL plans to continue to work with multiple governmental and non-governmental organizations to promote dietary salt reduction towards the World Health Organization (WHO) recommendations.
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Norm R C
authors.initials: NR
authors.lastname: Campbell
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Daniel T
authors.initials: DT
authors.lastname: Lackland
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Liu
authors.initials: L
authors.lastname: Lisheng
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Xin-Hua
authors.initials: XH
authors.lastname: Zhang
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Nilsson
authors.affiliation: 1 Libin Cardiovascular Institute of Alberta, University of Calgary, 3280 Hospital Drive NW, Calgary Alberta, T2N 4Z6, Canada ; 2 Department of Neurosciences, College of Medicine, Medical University of South Carolina, Charleston, USA ; 3 Beijing Hypertension League Institute, Fu Wai Hospital, Beijing, China ; 4 Beijing Hypertension League Institute, Beijing 100037, China ; 5 Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden ; 6 World Hypertension League, 415 Bass Lane, Corvallis, Montana 59828, USA.
authors.forename: Mark L
authors.initials: ML
authors.lastname: Niebylski
keywords: Salt; blood pressure; hypertension; public health; sodium